Delivery Order SPE2DB20D3103-SPE2DB24FM4G5
- Not listed
- The U.S. government agency's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $8,655.98, is for the delivery of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. This contract does not have a set-aside designation. The award is part of a larger...
- The Defense Logistics Agency awarded a delivery order valued at $44,900.61 to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in quantities of 30 count units. This firm fixed-price delivery order, with an ultimate completion date of May 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $5,253.34 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit quantity. The contract utilizes firm fixed price pricing with no set-aside designation and is scheduled for completion by May 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $43,857.85 to AmerisourceBergen Drug Corp for DELSTRIGO 100-300-300 mg tablets (30-count units) with a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by November 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,086.70 to AmerisourceBergen Drug Corp for Delstrigo 100-300-300 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a non-competitive, non-set-aside procurement issued on December 23, 2025. The award is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,241.36, is for the delivery of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 7, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit package. This competitively awarded, non-set-aside delivery order has a ceiling value of $10,080.18 and a firm fixed price structure, with an ultimate completion date of May 9, 2025. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. Delstrigo is an antiretroviral...
- The Defense Logistics Agency awarded a $7,385.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562070903 DELSTRIGO 100-300-300 MG TAB UU 30S. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the HIV/AIDS medication to a location in Conshohocken, Pennsylvania by September 7, 2023 to support the Department of Defense's medical readiness and treatment programs. No subcontractors or set aside designations were...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,934.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. This delivery order contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not designated as a set-aside. The company also...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a potential value of $5,186.67. The award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM4G5Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a specialty pharmaceutical product. The contract has a completion date of January 29, 2024 and a potential value of $17,807.95. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 1/26/24 |